TipRanks
Advertisement
Advertisement

DE:137 Stock Latest News

Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed
RatingsAldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed
2d ago
ALDX
Aldeyra Pursues FDA Dispute Over Dry Eye Drug
PremiumCompany Announcements
Aldeyra Pursues FDA Dispute Over Dry Eye Drug
3d ago
8K
ALDX
Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap
PremiumThe Fly
Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap
3d ago
ALDX
Aldeyra sees operational cash runway into 2029
PremiumThe Fly
Aldeyra sees operational cash runway into 2029
3d ago
ALDX
Analyst Maintains Hold on Aldeyra Amid FDA Uncertainty Over Reproxalap’s Regulatory Path
PremiumRatings
Analyst Maintains Hold on Aldeyra Amid FDA Uncertainty Over Reproxalap’s Regulatory Path
2M ago
ALDX
Aldeyra Therapeutics Leases New Concord Headquarters Space
PremiumCompany AnnouncementsAldeyra Therapeutics Leases New Concord Headquarters Space
2M ago
8K
ALDX
ALDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALDX Upcoming Earnings Report: What to Expect?
2M ago
ALDX
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
Premium
Company Announcements
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
4M ago
8K
ALDX
Aldeyra Updates Reproxalap Outlook and Extends Cash Runway
PremiumCompany Announcements
Aldeyra Updates Reproxalap Outlook and Extends Cash Runway
5M ago
8K
ALDX
Aldeyra Therapeutics Announces Upcoming Board Member Departure
PremiumCompany Announcements
Aldeyra Therapeutics Announces Upcoming Board Member Departure
5M ago
8K
ALDX
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
PremiumClass Action
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
6M ago
ALDX
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
PremiumCompany Announcements
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility
6M ago
8K
ALDX
Maintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
PremiumRatingsMaintaining Hold on Aldeyra as FDA CRL Clouds Reproxalap’s Dry Eye Path and Lowers Approval Odds
7M ago
ALDX
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
7M ago
ALDX
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
Premium
The Fly
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
7M ago
ALDX
FDA Issues Second Complete Response Letter for Reproxalap
PremiumCompany Announcements
FDA Issues Second Complete Response Letter for Reproxalap
7M ago
8K
ALDX
Aldeyra options imply 10.9% move in share price post-earnings
PremiumThe Fly
Aldeyra options imply 10.9% move in share price post-earnings
7M ago
ALDX
Aldeyra Therapeutics Announces Chief Development Officer Resignation
PremiumCompany Announcements
Aldeyra Therapeutics Announces Chief Development Officer Resignation
9M ago
8K
ALDX
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
PremiumRatings
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Drug Development and Robust Investment Potential
10M ago
ALDX
Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
PremiumThe FlyMidday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
10M ago
F
F
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
Premium
Ratings
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
10M ago
ALDX
Unusually active option classes on open December 16th
Premium
The Fly
Unusually active option classes on open December 16th
10M ago
F
BP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >